Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Escitalopram efficacy in depression: a cross-ethnicity examination of the serotonin transporter promoter polymorphism.

Journal of clinical psychopharmacology - 1 Oct 2014

Bousman Chad A, Sarris Jerome, Won Eun-Soo, Chang Hun-Soo, Singh Ajeet, Lee Hwa-Young, Ham Byung-Joo, Tan Chay-Hoon, Lee Min-Soo, Ng Chee H

Abstract excerpt

Current evidence suggests that polymorphism in the serotonin transporter gene (5-HTTLPR) predicts antidepressant efficacy in whites but less so in Asians. However, it is not clear whether this effect can be observed for specific types of antidepressant drugs. White (n = 47) and Korean (n = 118) participants with major depressive disorder were treated with escitalopram and assessed over 8 weeks. Among those with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Asian People

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Citalopram

Share to Depressive Disorder, Major

Share to Promoter Regions, Genetic

Share to Serotonin Plasma Membrane Transport Proteins

Share to Single-Blind Method

Share to White People

Source

Identifiers

PMID: 24943391
DOI: 10.1097/JCP.0000000000000165

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Escitalopram efficacy in depression: a cross-ethnicity examination of the serotonin transporter promoter polymorphism.PMID 24943391Read ↗

Association of Serotonin Transporter Gene 5HTTLPR rs25531 Polymorphism With Escitalopram Efficacy in Patients With Major Depressive Disorder.Semantic proximity Read ↗

Association between functional polymorphisms in serotonin transporter gene (SLC6A4) and escitalopram treatment response in depressive patients in a South Indian population.Semantic proximity Read ↗

Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depressionSemantic proximity Read ↗

Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.Semantic proximity Read ↗

Serotonin transporter genotype and function in relation to antidepressant response in Koreans.Semantic proximity Read ↗

Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder.Semantic proximity Read ↗

Moderation of antidepressant response by the serotonin transporter gene.Semantic proximity Read ↗

Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.Semantic proximity Read ↗

5-HTTLPR-rs25531 and Antidepressant Treatment Outcomes in Korean Patients with Major Depression.Semantic proximity Read ↗

Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults.Semantic proximity Read ↗

Comparison of antidepressant efficacy-related SNPs among Taiwanese and four populations in the HapMap database.Semantic proximity Read ↗

Response to citalopram is not associated with SLC6A4 genotype in African-Americans and Caucasians with major depression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.